宫颈小细胞癌12例临床分析  

Clinical Analysis of 12 Cases with Small Cell Cervical Carcinoma

作　　者：姜智[1] 裴红[2] 曲渊[2] 

机构地区：[1]南京大学医学院研究生班,江苏南京210009 [2]江苏省肿瘤医院,江苏南京210009

出　　处：《肿瘤学杂志》2005年第4期261-262,共2页Journal of Chinese Oncology

摘　　要：[目的]探讨宫颈小细胞癌(SCCC)确诊方法及治疗、预后。[方法]回顾分析1989年4月￣2004年4月收治的12例SCCC患者的临床资料。[结果]12例患者均经病理检查确诊,其中4例通过免疫组化证实。12例SCCC患者中5例放弃治疗。另7例均在术前术后化疗,其中4例死亡,生存期分别为13、17、26、34个月,2例失访,1例仍在随访中(39个月)。[结论]主要依赖病理组织形态和免疫组化将宫颈小细胞癌从普通宫颈癌中区分开。基本治疗原则采用术前放、化疗,手术加术后化疗的综合治疗方案。预后差。[Purpose] To investigate the diagnosis,treatment and prognosis in small cell cervical carcinoma（SCCC）. [Methods] Data of 12 cases with small cell cervical carcinoma from April 1989 to April 2004 were analysed retrospectively. [Resuhs] Of 12 cases pathologically proved, 4 cases were immunohistochemically confirmed. Five cases gave up treatment, and the other 7 cases underwent preoperative and/or postoperative chemotherapy. Of the 7 cases, 4 died with survival of 13, 17, 26, 34 months respectively; 2 cases lost follow up; and 1 case was in followed up. [Conclusion] Immunohistochemical and histopathological procedures were the main procedures to differentiate SCCC from common cervical cancer. The prognosis of SCCC is very poor.Combination therapy with preoperative radiation or chemotherapy, surgical treatment and postoperative chemotherapy should be undertaken.

关 键 词：宫颈肿瘤 癌 小细胞 综合疗法 预后 

分 类 号：R737.33[医药卫生—肿瘤]